Hematology experts Gareth Morgan, MD, PhD, and Faith Davies, MD, have joined the Center for Blood Cancers at NYU Langone Health’s Perlmutter Cancer Center and will lead its multiple myeloma program.
About Dr. Morgan
Dr. Morgan, the Center’s Director of Multiple Myeloma Research, previously served as Director of the Myeloma Institute, Deputy Director of the Winthrop P. Rockefeller Cancer Institute, and Professor of Hematology at the University of Arkansas for
Gareth Morgan, MD, PhD
Medical Sciences. There, he directed numerous studies of the genetics and biology of myeloma. Dr. Morgan’s particular focus is on developing new targeted treatments for high-risk variants of the disease.
Dr. Morgan received his doctorate from the University of London, where he studied the genetics of leukemia, and his medical degree from the Welsh National School of Medicine. He completed fellowships in hematology and pathology at the Royal College of Physicians in London. In 2014, he was a scholar at the Arkansas Research Alliance, before completing a fellowship at the American College of Physicians in 2015.
About Dr. Davies
Dr. Davies will serve as Director of the Center’s Clinical Myeloma Program and will direct a new inpatient facility in the Kimmel Pavilion. She joins Perlmutter Cancer Center from the University of Arkansas for Medical Sciences, where she was
Faith Davies, MD
Medical Director of the Myeloma Institute and Professor of Medicine. Her current research focuses on the genetic, biologic, and radiologic theranostic markers to improve outcomes for patients with myeloma.
Dr. Davies received her Bachelor of Medicine and medical degrees from the University of Wales College of Medicine and completed her hematology specialty training in the United Kingdom. She completed fellowships at the Royal College of Pathologists and American College of Physicians, and also at the University of London. ■
